Learn More
CD267 (TACI) Monoclonal Antibody (165609), Invitrogen™
Mouse Monoclonal Antibody
Brand: Invitrogen MA523781
Additional Details : Weight : 0.00010kg
Description
In direct ELISAs and Western blots, no cross-reactivity with recombinant mouse TACI or recombinant human BCMA is observed. Reconstitute at 0.5 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
CD267 (TACI) Monoclonal antibody specifically detects CD267 (TACI) in Human samples. It is validated for ELISA, Immunohistochemistry, Neutralization, Western Blot.Specifications
CD267 (TACI) | |
Monoclonal | |
0.5 mg/mL | |
PBS with 5% trehalose and No Preservative | |
O14836 | |
TNFRSF13B | |
Mouse myeloma cell line NS0-derived recombinant human TACI/TNFRSF13B Ser2-Thr166 | |
500 μg | |
Primary | |
Human | |
Antibody | |
IgG1 |
ELISA, Immunohistochemistry, Neutralization, Western Blot | |
165609 | |
Unconjugated | |
TNFRSF13B | |
1200009E08Rik; CD267; CVID; CVID2; IGAD2; NEWGENE_1595998; RYZN; TACI; TNF receptor superfamily member 13B; Tnfrsf13b; TNFRSF14B; transmembrane activator and calcium-modulating and cyclophilin ligand interactor; transmembrane activator and CAML interactor; tumor necrosis factor receptor 13B; tumor necrosis factor receptor superfamily member 13B; tumor necrosis factor receptor superfamily, member 13B | |
Mouse | |
Protein A/G | |
RUO | |
23495 | |
-20° C, Avoid Freeze/Thaw Cycles | |
Lyophilized |